1. Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors

   • Francesco Locatelli
   • Roberto Minutolo
   • Lucia Del Vecchio

   Review Article 09 November 2022 Pages: 1565 - 1589

2. Empagliflozin: A Review in Symptomatic Chronic Heart Failure

   • James E. Frampton

   Adis Drug Evaluation 14 November 2022 Pages: 1591 - 1602

   

3. Darinaparsin: First Approval

   • James E. Frampton

   AdisInsight Report 04 November 2022 Pages: 1603 - 1609

   

4. Correction to: Darinaparsin: First Approval

   • James E. Frampton

   Correction 14 November 2022 Pages: 1611 - 1611

5. Teclistamab: First Approval

   • Connie Kang

   AdisInsight Report 10 November 2022 Pages: 1613 - 1619

   

6. Valemetostat Tosilate: First Approval

   • Susan J. Keam

   AdisInsight Report Open access 15 November 2022 Pages: 1621 - 1627